Log In
Print this Print this

ABT-806 (formerly mAb806)

Also known as: formerly ch806

  Manage Alerts
Collapse Summary General Information
Company Life Science Pharmaceuticals Inc.
DescriptionHumanized recombinant IgG1k mAb that targets a tumor-specific epitope of EGFR
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today